Thomas Jefferson University

Jefferson Digital Commons
Department of Pathology, Anatomy, and Cell
Biology Faculty Papers

Department of Pathology, Anatomy, and Cell
Biology

8-4-2018

Modeling the dynamics of human liver failure post liver resection
Babita Verma
Thomas Jefferson University; Indian Institute of Technology-Madras, Chennai

Pushpavanam Subramaniam
Indian Institute of Technology-Madras, Chennai

Rajanikanth Vadigepalli
Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/pacbfp
Part of the Pathology Commons

Let us know how access to this document benefits you
Recommended Citation
Verma, Babita; Subramaniam, Pushpavanam; and Vadigepalli, Rajanikanth, "Modeling the
dynamics of human liver failure post liver resection" (2018). Department of Pathology, Anatomy,
and Cell Biology Faculty Papers. Paper 239.
https://jdc.jefferson.edu/pacbfp/239
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Pathology, Anatomy, and Cell Biology Faculty Papers by an authorized
administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

processes
Article

Modeling the Dynamics of Human Liver Failure Post
Liver Resection
Babita K. Verma 1,2 , Pushpavanam Subramaniam 2 and Rajanikanth Vadigepalli 1, *
1

2

*

ID

Daniel Baugh Institute for Functional Genomics/Computational Biology, Department of Pathology,
Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA;
ch14d207@smail.iitm.ac.in
Department of Chemical Engineering, Indian Institute of Technology-Madras, Chennai 600036, India;
spush@iitm.ac.in
Correspondence: rajanikanth.vadigepalli@jefferson.edu; Tel.: +1-215-955-0576

Received: 29 June 2018; Accepted: 1 August 2018; Published: 4 August 2018




Abstract: Liver resection is an important clinical intervention to treat liver disease. Following liver
resection, patients exhibit a wide range of outcomes including normal recovery, suppressed recovery,
or liver failure, depending on the regenerative capacity of the remnant liver. The objective of this
work is to study the distinct patient outcomes post hepatectomy and determine the processes that
are accountable for liver failure. Our model based approach shows that cell death is one of the
important processes but not the sole controlling process responsible for liver failure. Additionally,
our simulations showed wide variation in the timescale of liver failure that is consistent with the
clinically observed timescales of post hepatectomy liver failure scenarios. Liver failure can take place
either instantaneously or after a certain delay. We analyzed a virtual patient cohort and concluded
that remnant liver fraction is a key regulator of the timescale of liver failure, with higher remnant liver
fraction leading to longer time delay prior to failure. Our results suggest that, for a given remnant
liver fraction, modulating a combination of cell death controlling parameters and metabolic load may
help shift the clinical outcome away from post hepatectomy liver failure towards normal recovery.
Keywords: liver regeneration; liver failure; liver resection; virtual patient; dynamic modeling;
cell death

1. Introduction
Liver regeneration is a unique repair mechanism underlying physiological recovery following
hepatic injury and enables surgical treatment as a viable clinical intervention into liver disease, small for
size liver transplant and live donor liver transplantation. The process of liver regeneration takes place
via hyperplasia and hypertrophy of hepatocytes as well as other liver resident cell types to reconstitute
the liver morphology and function. In this process, the liver parenchymal cells, that is, differentiated
post-mitotic hepatocytes, respond to signals from non-parenchymal cells that are stimulated by the
hepatic injury and re-enter cell cycle, leading to multiple rounds of cell proliferation, thus compensating
for the lost tissue mass [1–3].
Liver resection is widely performed for hepatocellular carcinoma (HCC), metastatic colorectal
cancer and benign liver disease [4]. Liver response to resection is also relevant in live donors for
liver transplantation, where the remnant liver in the donor needs to regenerate after removal of
a portion of the liver for transplantation in the recipient. Advances in surgical techniques and expertise,
careful patient selection and post-operative patient care have resulted in better clinical outcomes in the
recent years [5]. However, Post hepatectomy liver failure (PHLF) is not uncommon due to a variety
of risk factors, including patient-based factors such as age, weight, diabetes [6,7]. Preexisting liver
disease such as cirrhosis, cholestasis, steatosis result in impaired liver regeneration [8].
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Surgery related factors such as excessive blood loss, portal vein hypertension, ischemia-reperfusion
injury and sepsis can result in liver failure. One of the most important factor that determines PHLF is
how much liver can be resected which depends on the functional capacity of the remnant liver fraction.
The percentage of liver failure post hepatectomy lies in the range of 0.7 to 9.1% [9]. To improve the
outcome post-surgery, it is important to be able to predict the liver regeneration response based on
patients’ pre- and post-operative assessment. Mathematical modeling of liver regeneration can play
a significant role in predicting the potential for PHLF prior to the surgical intervention, thus enabling
consideration of alternative interventions to prevent or reduce chances of PHLF.
In this study, we started with our previously developed computational model of liver regeneration [10]
and fine-tuned the parameters based on liver volumetric data from patients that underwent liver
resection [11]. The main objective of this work is to model the dynamics of the liver failure scenario
following a surgical resection. We focused on the model parameters that control the cell death process
and generated a virtual patient cohort by sampling across the parameter space involving metabolic
load and cell death sensitivity. We employed these virtual patients to analyze different modes of
potential response; normal recovery, suppressed recovery and liver failure. Our simulations revealed
wide variation in the timescale of liver failure consistent with the range of observed timescales in
human PHLF scenarios. Simulations indicate that liver failure can either happen instantaneously
or after a varying delay. We analyzed the distribution of this delay in a virtual patient cohort and
found that the remnant liver fraction plays a significant role in controlling the time of delay in liver
failure cases. Specifically, our simulations suggest that lower remnant liver fraction can lead to faster
timescale of failure, depending on a balance of a subset of intrinsic parameters. We analyzed the effect
of these controlling parameters corresponding to the metabolic load and cell death sensitivities on the
overall cell death post resection. Our results suggest that specific combinations of these parameters
can lead to a reasonable match to the clinically observed timescales of PHLF.
2. Materials and Methods
2.1. Mathematical Model
The mechanism of liver regeneration involves increase in portal pressure and production of
cytokines from the Kupffer cells (resident macrophages in the liver). The cytokines activate the
hepatocytes resulting in the priming and initiation of hypertrophy of the cells. Once the hepatocytes
are primed they become responsive to the growth factor released from extracellular matrix via the
action of matrix metalloproteinases (MMPs), as a consequence of which the parenchymal cells advance
into the cell cycle and replicate leading to hyperplasia. The mathematical model (Cook et al. [10])
considered for this work incorporates the above-mentioned processes using eleven ordinary differential
equations representing the hepatocytes in the three phases of the cell cycle quiescent (Q), priming
(P) and replicating (R) states. The model comprises of seven equations for the molecular regulation,
three equations for the cell state balances and the last equation accounts for relative cell mass growth,
that is, hypertrophy. The system of equations is considered lumped since we assume the process of
regeneration to be homogeneous in the remaining liver mass. The model equations are:
dQ
= −k QP ([ IE] − [ IE0 ]) Q + k RQ [ ECM] R + kreq σreq P − k cd σcd Q
dt

(1)

dP
= k QP ([ IE] − [ IE0 ]) Q − k PR ([ GF ] − [ GF0 ]) P − kreq σreq P − k cd σcd P
dt

(2)

dR
= k PR ([ GF ] − [ GF0 ]) P − k RQ [ ECM] R + k prol R − k cd σcd R
dt

(3)

VJ AK [ IL6]
M
d[ IL6]
= k IL6
−
− κ IL6 [ IL6] + k1
dt
N + ε [ IL6] + K J AK
M

(4)
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VJ AK [ IL6]
d[ J AK ]
− κ J AK [ J AK ] + k2
=
J AK
dt
[ IL6] + K M

(5)

VST3 [ J AK ][ proSTAT3]2
d[STAT3]
=
SOCS3
dt
[ proSTAT3]2 +K ST3
)
M (1+[ SOCS3] /K I
VSOCS3 [STAT3]
VIE [STAT3]
− [STAT3]+K IE − [STAT3]+KSOCS3 − κST3 [STAT3] + k3
M
M

(6)

VSOCS3 [STAT3]
d[SOCS3]
− κSOCS3 [SOCS3] + k4
=
dt
[STAT3] + K SOCS3
M

(7)

d[ IE]
VIE [STAT3]
=
− κ IE [ IE] + k5
IE
dt
[STAT3] + K M

(8)

d[ GF ]
M
= k GF
− k up [ GF ][ ECM] − κ GF [ GF ] + k7
dt
N+ε

(9)

d[ ECM ]
= −kdeg [ IL6][ ECM] − κ ECM [ ECM] + k6
dt


dG
M
= kG
− kG M
dt
N+ε

(10)
(11)

where,
ε = 0.01


θ − ( N + ε)/M
σcd = 0.5 1 + tanh cd
β cd



θreq − [ GF ]
σreq = 0.5 1 + tanh
β req

(12)

N = Q + G ( P + R)

(15)



k1 =

VJ AK
J AK
1 + KM

− k IL6

k2 = κ J AK −
k3 =

−

M
+ κ IL6
Nss + ε
VJ AK

VSOCS3
1+K SOCS3
M

(14)

(16)
(17)

J AK

1 + KM

VST3 [ proSTAT3]2
SOCS3
[ proSTAT3]2 +K ST3
)
M (1+1/K I

(13)

+

VIE
IE +
1+ K M

(18)

+ κST3

k4 = −

VSOCS3
+ κSOCS3
1 + K SOCS3
M

(19)

VIE
+ κ IE
IE
1 + KM

(20)

k5 = −

k6 = kdeg + κ ECM
k7 = −k GF

M
+ k up + κ GF
NSS + ε

NS S = 0.99

(21)
(22)
(23)

Here, k1 . . . k7 are constants defined such that the molecular species are at steady state under
the normal functioning of the liver. The initial conditions for solving the above-mentioned system of
equations are:
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Q0 = remnant liver fraction; P0 = 0; R0 = 0
[IL60 ] = 1; [JAK0 ] = 1; [STAT30 ] = 1; [SOCS30 ] = 1;
[IE0 ] = 1; [GF0 ] = 1; [ECM0 ] = 1
G0 = 1
N0 = Q0 + G0 ( P0 + R0 ) = Q0

(24)

The system of equations for this model are stiff and were solved in Matlab using ode15s. The initial
conditions for the quiescent state and molecular species signify the steady state under normal
functioning of liver in which both primed and replicating cells are at zero levels.
2.2. Defining Virtual Patient Cohort
We employed the emerging approach of simulating a cohort of virtual patients [12,13] to assess the
distribution of potential responses, in an attempt to account for the clinically observed wide variation
of outcomes. In the present study, the virtual patients were defined based on sampling key parameters
within a range of 2X, 3.125X and 7X, respectively, from the nominal values for the three controlling
parameters (M, βcd , θcd ). The sampling was performed in an unbiased approach to span the full range
of the three-dimensional volume using Sobol sampling [14,15] to generate a cohort of 9000 virtual
patients. The range of the controlling parameters were so chosen to capture the different response
modes in the cohort of virtual patients under study.
2.3. Identification of Distinct Response Modes
The simulated results were classified into distinct response modes based on the level of liver mass
fraction at the end of 2.5 years post liver resection—Normal recovery: 0.9–1.1, Suppressed recovery:
<0.8. Patients are classified as exhibiting a liver failure scenario if the liver mass fraction dropped below
0.1 by 2.5 years post liver resection. The liver failure cases were further classified as exhibiting delayed
failure or immediate failure based on the time taken to undergo failure. Immediate liver failure was
deemed as occurring if the liver mass fraction is below 0.1 within the 5th day post resection and the
remaining liver failure cases were classified as corresponding to the delayed failure scenarios.
2.4. Parameter Optimization
All the 33 parameters of the model (Table A1) were optimized using fmincon in Matlab using
the elastic net approach with the regularization weightage of 0.001 for both Ridge and Lasso [16,17].
We explored the effect of using different regularization weights over a wide range from 0.0001 to
0.1. However, some of the regularization weights resulted in an integration error or terminated with
a premature solution for a subset of the patients. Following this approach resulted in patient-specific
regularization weights and thus likely yielded an overfitted model in some cases. We found that the
regularization weight of 0.001 worked for all the patients and thus avoided over-fitting of the model.
The liver fraction at any given time point at and post resection is calculated as the ratio of
remnant liver volume to the total liver volume prior to resection, based on the volumetric data from
Yamamoto et al. [11]. However, note that the present ODE model considers fractional liver mass and
not volume, as we incorporated the tissue growth dynamics in the model. For the purpose of the study,
we considered the liver volume fraction information from the clinical data set to be equivalent to the
liver mass fraction calculated in the simulations, under a reasonable assumption that the density of
the tissue does not alter significantly after resection. This also permits us to compare the response
profiles across individual patients that may have wide variation in the liver size. The model dynamics
are sensitive to the three controlling parameters; metabolic load (M) and cell death sensitivities
(βcd , θcd ). The initial guess for the parameter optimization was considered from the parameter values
of Cook et al. [10] for humans, except for the values of the three controlling parameters (M, θcd , βcd ).
These values were fixed from a representative case of a virtual patient undergoing delayed liver failure
(Table A2).
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2.5. Clinical Dataset
The human liver volumetry dataset used for the present work was obtained from the published
literature [11], which contains information about the liver volume post resection in 196 patients.
The dataset was analyzed for volume changes over time and a subset of 7 patients that showed liver
failure were considered for further analysis and matching to model dynamics.
2.6. Model Repeatability and Reproducibility
The model equations and parameters for various simulations presented in the manuscript are
available in the main text and Appendix, respectively. The Matlab code for virtual patient cohort
simulation and response mode classification is available in the supplemental file S1. The Matlab code
for parameter optimization is available as supplemental file S2. The network model in Equations
(1)−(24) was independently implemented in the Systems Biology Markup Language (SBML) by
a laboratory colleague not involved in the original study, based on the equations and information
provided in the manuscript. This model was set up based on the parameter values in the “Nominal
Value” column of the Table A2 in the Appendix. An SBML code corresponding to this model
implementation is included as supplemental file S3. Select figures for exploring the results from
virtual patient cohort analysis are provided in the supplement in the Matlab FIG format. A brief
discussion of the biological context and assumptions motivating the model is included in the Methods
and some of the limitations were detailed in the Discussion.
3. Results
3.1. Modeling the Range of Response to Liver Resection in a Virtual Patient Cohort
We started with a computational model of liver regeneration, previously developed by our
group [10]. The mathematical model of Cook et al. [10] considers hypertrophy and hyperplasia
in liver following resection [18], by accounting for hepatocytes in different phases of the cell cycle.
The molecular aspects of this network model of liver regeneration are largely based on the dynamics
of cytokine and growth factor pathways stimulated by the liver resection injury. Immediately post
resection, the hepatocytes undergo priming in response to the cytokines released by Kupffer cells,
activating the Janus Kinase (JAK)—Signal Transducer and Activator of Transcription (STAT) signaling
pathway in the hepatocytes. Primed hepatocytes become responsive to the growth factors linking
the priming phase to the cell-cycle progression. In the present computational model, response to
liver regeneration following partial hepatectomy is triggered by metabolic load per unit liver mass.
The network model is shown in Figure 1A and the corresponding systems biology graphic notation
(SBGN) [19] diagram for the liver regeneration model is provided as supplementary information
(Figure S1). This model can exhibit distinct modes of response ranging from complete recovery of
liver mass to liver failure. As an illustrative example, Figure 1B shows the regeneration profile of two
virtual patients that underwent 1/3rd liver resection but showed opposite responses, that is, recovery
versus failure. Phase portrait [20,21] for the same virtual patients is shown in Figure 1C, depicting
the evolution of hepatocytes in different phase of the cell cycle over time. Depending on the model
parameters which corresponds to the two different virtual patients, for the same initial remnant liver
mass, there exist two different stable steady states corresponding to recovery and failure.
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Figure 1. (A) Network diagram of the liver regeneration model. (B) Regeneration profile of two virtual
patients with liver recovery and failure respectively for 1/3rd resection, their model parameters are
same as Cook et al. but with different values of the controlling parameters; Recovery: M = 11.4645,
βcd = 0.0064, θcd = 0.0262; Failure: M = 10.7312, βcd = 0.0219, θcd = 0.0224. (C) Phase plane of the
same virtual patients showing recovery and failure with the evolution of hepatocytes in quiescent and
replicating phase of the cell cycle.

We simulated the dynamics of liver mass in response to resection in a virtual patient cohort
generated by varying key model parameters (see Methods). We analyzed the distribution of responses
in the virtual patient cohort and classified the virtual patients into multiple response categories based
on the liver mass outcome at the end of 2.5 years following resection. We analyzed the responses of
9000 virtual patients to unravel the mechanisms that lead to different response modes. The virtual
patient cohort was generated by varying the metabolic load and the cell death sensitivities via Sobol
sampling, while the remaining 30 parameters (out of 33) were held at the same values as that of
Cook et al. [10] for the case of human. We chose to vary metabolic load (M) and cell death sensitivities
(βcd ,θcd ) from the 33-dimensional parameter space since these 3 parameters control the cell death
process as incorporated in the network model (see Equations (1)–(3) and (13)). In this formulation,
liver failure is considered as likely to occur in two ways: (i) either the liver regeneration does not
commence at the rate necessary to meet the increased functional demand post resection, or (ii) even as
the regeneration process is initiated, the cell death rate is sufficiently high as to result in liver failure [22].
Our simulation-based analysis suggests that the virtual patients can be categorized into four
distinct classes based on the response to the resection: normal recovery, suppressed recovery, delayed
failure and immediate failure. The regeneration profiles of different classes of response for 10%
and 33.3% are shown in Figure 2A,B,D,E. We note that the suppressed patients did not show fast
recovery immediately after surgery. In Figure 2C we show a representative patient data demonstrating
recovery post-surgery from Yamamoto et al. [11]. From Figure 2F we observe that a subset of the
virtual patients exhibited instantaneous liver failure, whereas others showed a delayed liver failure),
demonstrating a good match in the timescale of the liver failure based on volumetric data from patients
in Yamamoto et al. [11]. Simulated regeneration profiles of liver failure response show a sudden
drop in fraction of liver either immediately post resection or after a delay of few days. However,
such a sudden drop was not readily apparent in the clinical data. It is unlikely that patients undergoing
liver failure would be subjected to liver volumetric analysis in the clinic. Also, in reality, the liver
mass does not become zero as is seen in the numerical simulations, since the patient’s body might
succumb to the non-functioning liver even before such condition of extremely low levels of liver mass
is reached. However, the drop in the liver mass in simulations is instructive on the dynamics of the
process, informing the potential trajectories taken by a range of patients, consistent with the wide
range of time delays observed in patients exhibiting liver failure [11].
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corresponding to the virtual patients that exhibited delayed failure for remnant liver fraction of 0.9 and
0.667 (Supplementary information Figures S2 and S3, Video S1, S2). The proportion of cases that
exhibited delayed liver failure varied from 8.73% to 40.22% of the total number of virtual patients
for remnant liver fraction of 0.9 and 0.667, respectively (i.e., 10% and 33.3% resection). At the same
time, the proportion of cases that exhibited suppressed recovery changed from 1.63% to 37.25% and
the proportion of normal recovery cases reduced from 37.23% to 8.17%, as the remnant liver fraction
decreased from 0.9 to 0.667 (i.e., increase in the level resection from 10% to 33%). This shift in the
response of different virtual patients with increasing resection implies that the remnant liver mass
significantly regulates the qualitative outcome of liver resection surgery. In the next section, we focus
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3.2. Cell Death as a Function of the Controlling Parameters in Different Classes of Patients
Following partial hepatectomy, both positive and negative stimulus are triggered resulting in liver
regeneration or failure based on a balance of these stimulus. Cell death is likely an important regulatory
process in liver regeneration, levels of which determine whether the organ can recover following injury.
Analysis of the cellular equations (Equations (1)–(3)) of the model along with the cell death sigmoidal
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−3 − 3.15 × 10−2 ]; M = 5.8507, θ = 0.0320. (B) θ = [3.2 × 10−3 − 3 ×
process.
(A)
β
=
[3.2
×
10
(A) βcd = [3.2 × cd
10−3 − 3.15 × 10−2]; M = 5.8507, θcd = 0.0320. (B) θcdcd = [3.2 × 10−3 − 3cd× 10−1]; M = 5.8507, βcd =
10−1 ]; M = 5.8507, βcd = 0.0045. (C) M = [0.59 − 11.7]; θcd = 0.0320, βcd = 0.0045. (D) βcd = [3.2 × 10−3
− 3.15 × 10−2 ] and M = 5.85 or 10, θcd = 0.0320.

We analyzed the cell death function of the 9000 virtual patients that were categorized for response
modes in Section 3.1. The cell death functions corresponding to the four response mode classes of
patients are shown in Figure 5. The cell death functions of both recovery classes, normal and suppressed
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growth, are steep and shifted towards lower remnant liver fraction (Figure 5A,B,E,F), which resulted
in almost negligible cell death at low levels of resection (i.e., high remnant liver fraction). The cell
death functions for the liver failure classes show wide variation and are more inclined as compared to
normal and suppressed recovery classes, resulting in higher cell death for any given level of resection
(Figure 5C,D,G,H). The ranges of cell death functions are overlapping across the response modes,
suggesting that cell death function is not the sole determining factor for classifying the fate of the
patient post resection surgery. Specifically, the level of resection also plays a crucial role in determining
the dynamics of liver recovery and potential failure.
Processes 2017, 5, x FOR PEER REVIEW
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Figure 5. The distribution of profiles of cell death function for the four classes of patients categorized
by the response mode to a given level of resection. (A,E) Normal growth. (B,F) Suppressed recovery.
(C,G) Delayed liver failure. (D,H) Immediate liver failure. (A–D) 10% resection and (E–H) 33.3% resection.

3.3. Comparison of Cell Death between Recovery versus Failure Scenarios for Varying Level of Resection
In this section, we compare the responses of two virtual patients showing liver recovery and
liver failure to different levels of resection to examine the distribution of responses. Figure 6A,D
shows the regeneration profiles of a representative normal recovery and a liver failure cases from the
virtual patient cohort for 1/3rd resection. The response profiles were simulated for different levels
of resection. The virtual patient shows recovery for varying levels of resection, until a threshold
value of 83%, beyond which liver failure occurred due to lack of a robust regenerative response
(Figure 6A). By contrast, the response of the patient with controlling parameters leading to liver failure
was insensitive to the level of remnant liver mass (Figure 6D). Simulations suggest that at higher levels
of resection (i.e., lower remnant liver fraction), the patient can exhibit an inverse response in which
the liver mass enters an initial recovery phase while undergoing a continuous loss of liver tissue that
overcomes the recovery, resulting in liver failure. The failure is reflected in the response profile as
a fast decline in the remnant liver fraction and the time delay of failure was longer with higher levels
of remnant liver mass (Figure 6D).
For the above two virtual patient cases, we examined the evolution of hepatocytes in quiescent
versus proliferating phase over time for different levels of resection. The corresponding projections
of the phase spaces shown in Figure 6B,E suggest the existence of two attractors, one corresponding
to failure and the other to recovery. For the first virtual patient case, a threshold of 83% resection
separates the two attractors, such that increasing level of resection results in a shift in the stability of the
system from one attractor to another, that is, exhibiting a transition from recovery to failure (Figure 6B).

Processes 2018, 6, 115

11 of 19

By contrast, the threshold of failure for the second virtual patient was low, likely corresponding to the
existence of only one attractor for this case that is associated to liver failure (Figure 6E). We compared
the cell death function for the two cases for uncovering potential differences over time. The surface
plots shown in Figure 6C,F correspond to the two virtual patient cases and the trajectories on the
surface depict the cell death process for a specific level of resection. For the first virtual patient case,
the cell death is negligible for low levels of resection as seen by the trajectories largely spanning the
lower part of the cell death function (Figure 6C). At a resection level beyond the threshold of failure,
there is a drastic change in the cell death profile with the trajectories distributed in the upper portion
of the cell death function, resulting in high cell death. In the second virtual patient case, the cell death
trajectories show initial fluctuations at low levels of the cell death function, before shifting upward
and saturating to the maximum cell death which leads to a fast decline in the remnant liver fraction
(Figure
6F).
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Figure 6. (A,D) Temporal profile of remnant liver fraction for two virtual patients for varying levels
of resection. These cases were chosen based on the recovery and failure outcomes respectively for
1/3rd resection. (Recovery: M = 11.4645, βcd = 0.0064, θcd = 0.0262; Failure: M = 10.7312, βcd = 0.0219,
θcd = 0.0224) The corresponding (B,E) phase plane and (C,F) cell death function for the two virtual
patients are shown.

3.4. Tuning the Model for Different Liver Failure Patients
The analysis so far has provided insights into the effect of key biochemical and biophysical
parameters in the liver regeneration process. We used this knowledge to tune the model parameters
to capture the timescale of response to resection as reflected in the volumetric liver data for the
patients that exhibited liver failure available in Yamamoto et al. [11]. Figure 7 shows the regeneration
profiles predicted and optimized parameters for 7 real patients who exhibited liver failure. The model
parameters were optimized for each patient-specific data set using elastic net (see Methods). The initial
values for parameter optimization were chosen such that the values of the controlling parameters
(M, θcd , βcd ) were set from a representative case of a virtual patient belonging to the class of delayed
liver failure and the remaining 30 parameters were set from Cook et al. [10]. The simulated liver
fraction profiles from models with patient-specific optimized parameters showed a good match with
the volumetric data and captured both the slow (ID114, 123, 131, 29) and fast (ID45, 245, 135) timescales
of liver failure (Figure 7A). Comparing the optimized parameters to the initial values show that the
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priming of hepatocytes and JAK-STAT pathway contribute to the difference in the timescale of liver
failure (Figure 7B). The table of optimized parameter values for the individual patients is given in
Appendix A.
The profiles of remnant liver fraction for the slow and fast timescale of liver failure cases are
shown in Figure 8A,F. The corresponding phase space portrait projection and the cell death functions
of patients undergoing liver failure at the slow and fast timescales are shown in Figure 8A–E and
Figure 8F–I, respectively. Even as the regeneration profiles of the patients with slow timescale of
response appear to match a suppressed recovery case, the phase plane depicts that the patients likely
undergo liver failure, as the fraction of remnant liver in each case is progressing towards the attractor
of zero levels. Analysis of the patient-specific cell death functions and trajectories suggest that the cell
death trajectories of patients showing slow timescale of failure were largely restricted to the lower
levels of cell death function. By contrast, the cell death trajectories of patients with relatively faster
timescale of liver failure continually progressed from lower levels with a steep ascent to reach maximal
levels of cell death function, corresponding to a rapid decline in the predicted liver fraction.
We note that the optimized values of the controlling parameters of all the patients were
similar (Appendix A) and yet the cell death trajectories were rather divergent across the patients
(Figure 8B–E,G–I). This is because cell death is not only dependent on the identified controlling
parameters but also on the remnant liver fraction, which depends on the regenerative processes
including priming pathways and proliferation. The parameters for the regenerative capacity are
different between the patients (Figure 7B) and these differences manifest in the net amount of recovery,
or lack thereof, in the fractional liver, indirectly affecting the cell death trajectory. Our simulations
suggest that patients with slow timescale of liver failure sustain low cell death for a longer duration
compared to the patients with a relatively faster timescale of failure that experience high cell death
with a rapid decline in the remnant liver fraction leading to failure and patient death. These results
from analysis of patient-specific model parameterization and simulation provide insights into how
the cell death trajectories likely control the timescale of response to resection, particularly for the liver
Processes
2017,cases.
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failure

Figure 7. (A) Temporal profile of fractional liver of different patients that exhibited liver failure.
The model fits are based on patient-specific optimized parameters obtained using elastic net.
(B) Optimized parameters scaled to the initial parameter values for the individual patients.
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Figure 8. (A,F) Phase plane of a select set of patients exhibiting liver failure. (B–E) Patient-specific cell
death functions and trajectories for patients with slow timescale of liver failure. (G–I) Patient-specific
cell death functions and trajectories for patients with fast timescale of liver failure.

4. Discussion
The focus of this study is to understand the interplay between the different processes that are
activated after a liver resection and can lead to post hepatectomy liver failure. We started with
a computational model of liver regeneration process based on the published cellular network model of
Cook et al. [10]. We simulated the model over a wide range of parameters and found that the model
captures the wide variability in patient outcomes of liver regeneration and accounts for the variation
in the observed timescales of liver failure. The variability in response to liver resection may arise due
to inter-individual differences in the sensitivity to injury, which is likely due to disease etiology as well
as intrinsic genetic factors [23]. For instance, hepatic steatosis alters the potential for cell survival and
proliferation after liver resection as compared to the normal liver [10,24].
We identified the controlling parameters in the model which govern the timescale of the post
hepatectomy liver failure in humans. These controlling parameters correspond to the metabolic load
and cell death sensitivities. We generated a cohort of virtual patients by varying the controlling
parameters and classified the virtual patients based on their model-predicted outcomes post liver
resection. Our analysis suggests an inverse relationship between the levels of resection on the
proportion of cases showing normal growth, suppressed recovery, with concomitant increase in
the liver failure cases. These results are consistent with expectations of increased potential for failure
with increasing level of resection in humans and animals [6]. Our model-based virtual patient analysis
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revealed that the parameter space corresponding to the transition from recovery to failure outcomes
corresponds to delayed liver failure and the proportion of the delayed liver failure is dependent on
the level of resection. These results show that the remnant liver fraction is an important decision
making variable that not only discriminates between liver failure and recovery but also governs the
timescale of failure especially when a patient experiences delayed liver failure. These results provide
new insights in interpreting the wide range of variation seen in clinical data sets [11].
Our model-based results on the critical role of a combination of cell death process and remnant
liver fraction in controlling the liver regenerative response is consistent with the findings from animal
studies showing that beyond a certain threshold of resection, cell death increases substantially, resulting
in high likelihood of failure [6,25]. Importantly, reducing the cell death rescues the animals from
undergoing failure after partial hepatectomy [26]. Similarly, preventing the hepatocyte death by
blocking mitochondrial permeability transition can improve liver regeneration even for low remnant
liver fraction in animals [27,28]. Our model-based results place these experimental findings in the
context of cellular networks that underlie the regeneration process, as well as point out additional
parameters that can be potentially manipulated to help shift the trajectory of the response modes to the
recovery zone. The key controlling parameters were determined such that their combination decided
the level of cell death that occurred post resection. With our analysis, we concluded that though cell
death is an important process which influences the liver regeneration it is not the sole factor which
determines liver failure. Liver failure is conditional upon the load and other perioperative conditions.
This is likely to be patient specific and needs to be correlated with epidemiological, clinical measures
and disease etiology [29]. Modulation of these additional factors likely improve the probability of liver
recovery and hence have the potential to yield additional clinical options to reduce the chances of liver
failure due to lack of regenerative response.
Various parameters of this model were derived based on biochemical data and animal/clinical
observations (Furchtgott et al. [30]; Cook et al. [10]). The validation relevant to our present study
is regarding the dynamics of liver failure. Model simulations predict a wide range of time to
failure, which is consistent with the variability of the time scale of liver failure, seen in human data
(Yamamoto et al. [11]). We note that the virtual patient analysis approach differs from patient-specific
modeling that identifies parameters for individual patients and then performs comparative analysis
across patients. By contrast, the virtual patient simulations are evaluated against the types of behavior
(e.g., recovery versus failure), distribution of outcomes (e.g., range of time scales of failure) and so
forth., that are exhibited in a cohort (An et al. [12,13]). In the present study, information from the virtual
patient analysis on delayed liver failure response was used for optimization of the model parameters
for patient-specific data, which were not used to build the original model. Our analysis identifies cell
death relevant parameters and metabolic load as key factors controlling the time scale of liver failure
post-surgical resection. These results are consistent with Yamamoto et al. [11] findings from analysis of
patient data that suggest the extent of blood loss during surgery as a key factor discriminating between
failure versus recovery scenarios. It is likely that perioperative factors such as blood loss manifest
their effects on liver at least partly through increased cell death and higher load on the remaining
functional organ.
Our study was focused on the regulatory networks at the cellular and pathway scales in the liver
during the response to resection. However, failure or success of the resection surgery also depends
on the recovery of the metabolic function in addition to the liver mass. The present computational
framework can be extended to incorporate metabolic components to account for relationship between
functional liver fraction and key metabolic functions, for example, glucose homeostasis [31], ammonia
metabolism and urea cycle [32], or genome-scale metabolic models [33]. Liver failure can also occur due
to extra-hepatic factors including immune response, as well as inter-organ metabolic and physiological
relationships. For example, hepatic encephalopathy is an important condition that is guarded against
by monitoring ammonia homeostasis, which is considered as a clinically-relevant indicator of liver
metabolic function after liver surgery [34]. These processes are not explicitly accounted for in
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the present network model. One can consider that metabolic load parameter serves as a lumped,
phenomenological factor that accounts for the stress on liver, with metabolic load per unit of liver
mass (M/N in Equations (4), (9) and (11)) serving as a stimulus for regeneration as well as cell
death [10,30,35]. Opportunities exist for integrating the liver regeneration model with multi-organ
physiology models to expand the utility of the model into a whole body context. The model- based
research discussed in this work on liver regeneration has been based on a lumped model considering
the hepatocyte functional states. This approach can be extended to incorporate functional states of
other liver cell types including hepatic stellate cells, sinusoidal endothelial cells and Kupffer cells
(resident macrophages of the liver) [36], as well as potential emerging rescue approaches such as stem
cell transplant [37]. Taken together, the above detailed extensions to the network model will permit
relating the key controlling parameters to inter-cellular, tissue-scale and whole body physiological
scale parameters and will likely provide additional insights into novel venues for clinical management
and intervention.
Our use of a virtual patient cohort approach helped delineate the key parameter intervals
and combinatorial dependencies that correspond to a wide range of predicted outcomes post
resection. Fruitful next steps could be to correlate these model-predicted parameter subspaces
to patient demographical data as well as preoperative clinical information and disease etiology.
Development of such a correspondence between patient information and model parameters is likely
to aid in generalized application of the dynamic modeling to a wide range of liver surgery scenarios.
Such a model-based approach informed by patient data to constrain the parameters can assist in clinical
decision making by predicting the categorical outcome prior to the clinical intervention. Specifically,
our model-based approach can aid in estimating the safe level of resection a patient can undergo along
with predicting the need for necessary manipulations of cell death sensitivities and metabolic load to
maximize the chances of recovery.
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Appendix A
Table A1. Nomenclature of the model parameters and values of upper and lower bounds used in
the optimization.
Parameter

Range

Description

M

1.00411–100.41126

Mechanical stress or increased nutrient and detoxification demand

kIL6

0.15–15

Rate of production of IL6 from non-parenchymal cells

κIL6

0.09–9

Rate of IL6 degradation

VJAK

2000–200,000

Maximum rate of activation of JAK

KJAK
M

1000–100,000

Concentration of JAK, when the rate of activation of JAK is half of
the maximum rate

κJAK

0.04–4

Rate of degradation of JAK

[proSTAT3]

0.01–20

Relative concentration of monomeric STAT3

VST3

75–7500

Maximum rate of STAT3 phosphorylation

KST3
M

0.04–40

Michaelis-Menten concentration of proSTAT3

κST3

0.05–1

Rate of dephosphorylation of proSTAT3

VSOCS3

14,000–34,000

Maximum rate of SOCS3 activation

KSOCS3
M

0.0004–0.001

Concentration of SOCS3, when it’s rate of activation is half the
maximum rate

κSOCS3

0.1–0.7

KSOCS3
I

0.005–0.025

VIE

150–350

KIE
M

15–21

κIE

3–7

Rate of degradation of IE gene

kdeg

5–9

Rate of degradation of ECM by MMPs

κECM

30–36

kGF

0.05–0.2

Rate of production of growth factor from non-parenchymal cells

κGF

0.1–0.35

Rate of degradation of growth factor

kup

0.04–0.08

Rate of binding of growth factor to ECM

kQP

0.005–0.009

Rate of hepatocytes transition from quiescence to primed state

kPR

0.003–0.006

Rate of hepatocytes transition from primed to replicating state

kRQ

0.04–0.065

Rate of hepatocytes transition from replicating to quiescence state

kprol

0.01–0.03

Rate of proliferation of hepatocytes

kreq

0.05–0.15

Rate of requiescence of primed hepatocytes

θreq

6–10

Requiescence parameter in the sigmoidal function (σreq ) defining
the threshold of requiescence

βreq

2–4

Requiescence parameter in the sigmoidal function (σreq ) defining
the threshold of requiescence

kcd

0.05–0.15

θcd

0.00110–0.11050

Cell death sensitivity parameter of the sigmoidal function (σcd )

βcd

0.00260–0.26046

Cell death sensitivity parameter of the sigmoidal function (σcd )
defining the cell death threshold

kG

0.0003–0.0007

Rate of degradation of SOCS3
SOCS3 inhibition constant on STAT3
Maximum rate of activation of IE gene
Concentration of IE gene, when it’s rate of activation is half the
maximum rate

Rate of degradation of ECM

Cell death rate of damaged hepatocytes

Rate of growth of relative cell mass
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Table A2. Table of the 33 model parameters optimized using the initial value as given in the table for
the 7 patients (studied in section 3.4) from Yamamoto et al. [11] that showed liver failure.
Patient Identification Number

Parameter

Nominal
Value

ID114

ID123

ID131

ID29

ID45

ID145

ID135

M
kIL6
κIL6
VJAK
KJAK
M
κJAK
[proSTAT3]
VST3
KST3
M
κST3
VSOCS3
KSOCS3
M
κSOCS3
KSOCS3
I
VIE
KIE
M
κIE
kdeg
κECM
kGF
κGF
kup
kQP
kPR
kRQ
kprol
kreq
θreq
βreq
kcd
θcd
βcd
kG

10.041128
1.5
0.9
20,000
10,000
0.4
2
750
0.4
0.1
24000
0.0007
0.4
0.015
250
18
5
7
33
0.113
0.23
0.06
0.007
0.0044
0.054
0.02
0.1
8
3
0.1
0.011050
0.026046
0.000657

10.7480
3.9280
3.9040
20,000
10,000
1.4695
6.1276
750.0337
1.0194
0.0987
24000
0.0007
0.4871
0.0139
250.12
19.1762
6.9573
6.3119
33.9672
0.1677
0.3384
0.0577
0.0079
0.0043
0.0517
0.0202
0.1407
9.9514
3.9615
0.1390
0.0117
0.0180
0.000588

10.0211
3.2484
0.7807
20,000
10,000
1.1701
3.0179
750.0022
1.2485
0.1614
24000
0.0007
0.3970
0.0149
250.01
18.1366
5.3009
7.2057
33.0645
0.1214
0.2453
0.0590
0.0069
0.0044
0.0536
0.0202
0.0999
8.2151
3.1587
0.1089
0.0099
0.0270
0.000601

10.0173
1.6583
0.9043
20,000
10,000
0.3941
1.9367
750.0003
0.4001
0.1000
24000
0.0007
0.4000
0.0150
250.00
18.0041
5.0022
7.0017
32.9999
0.1130
0.2300
0.0600
0.0070
0.0044
0.0540
0.0200
0.1000
7.9998
3.0021
0.1000
0.0111
0.0257
0.000613

10.0396
1.5000
0.9000
20,000
10,000
0.4000
1.9736
750.0001
0.4000
0.1000
24000
0.0007
0.4000
0.0150
249.99
18.0055
4.9925
6.9977
33.0004
0.1130
0.2300
0.0600
0.0070
0.0044
0.0540
0.0200
0.1000
7.9994
3.0000
0.1000
0.0111
0.0249
0.000614

9.9112
1.0530
1.0276
20,000
10,000
0.5844
1.9422
750.0006
0.4115
0.1017
24000
0.0009
0.1913
0.0150
249.99
18.0474
4.9951
7.1109
32.9871
0.1128
0.2291
0.0598
0.0056
0.0034
0.0509
0.0277
0.1308
7.9845
2.9657
0.1001
0.0108
0.0198
0.000400

10.0552
1.4620
0.9117
20,000
10,000
0.4330
1.9866
750.0000
0.4096
0.1152
24000
0.0007
0.3855
0.0147
249.99
18.0014
5.0061
6.9982
33.0004
0.1166
0.2298
0.0600
0.0070
0.0044
0.0507
0.0220
0.1013
8.0009
2.9990
0.1006
0.0128
0.0260
0.000497

10.0425
1.4464
0.9800
20,000
10,000
0.3804
1.9897
749.9999
0.3752
0.1116
24000
0.0007
0.3847
0.0150
249.99
17.9778
4.9493
7.0171
32.9939
0.1103
0.2302
0.0600
0.0070
0.0044
0.0547
0.0144
0.0987
8.0182
2.9563
0.1003
0.0114
0.0234
0.000574
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